KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Yeon Hee Park

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 11건 중 1-11 번을 표시중입니다.

1 Article A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer 정경해 ; Cassandra Slader ; Chien-Ting Liu ; et al 2021
2 Article A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer 정경해 ; Cassandra Slader ; Chien-Ting Liu ; et al 2021
3 Article Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib 정경해 ; Jee Hyun Kim 7 ; Ji-Yeon Kim ; et al 2020
4 Article Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer Peter Schmid ; Javier Cortes ; Rebecca Dent ; et al 2022
5 Article Exploratory analysis of biomarkers associated with clinical outcomes from the study of palbociclib plus endocrine therapy in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer Soohyeon Lee ; Kyunghee Park ; Gun Min Kim ; et al 2022
6 Article Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) 고수진 ; 정경해 ; Gun Min Kim ; et al 2020
7 Article Phase II study to investigate the efficacy of trastuzumab biosimilar (Herzuma®) plus treatment of physician's choice (TPC) in patients with heavily pretreated HER-2+ metastatic breast cancer (KCSG BR 18-14/KM10B) Sung Hoon Sim ; Jeong Eun Kim ; Min Hwan Kim ; et al 2022
8 Article Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13) 안진희 ; 오호석 ; 정경해 ; et al 2021
9 Article Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer Hee Kyung Ahn ; Sung Hoon Sim ; Koung Jin Suh ; et al 2022
10 Article Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis Guy Jerusalem ; Yeon Hee Park ; Toshinari Yamashita ; et al 2022
11 Article Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi ; William Jacot ; Toshinari Yamashita ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.